The dispute involved payments made by Ranbaxy, now merged with Sun Pharmaceutical Industries Ltd, to Teva Israel under a 2011 settlement relating to the US launch of generic atorvastatin.
The dispute involved payments made by Ranbaxy, now merged with Sun Pharmaceutical Industries Ltd, to Teva Israel under a 2011 settlement relating to the US launch of generic atorvastatin.
<iframe src="https://hindustansphere.com/embed/cluster/cb463e7c2182069a52cd033433f296535cc6c3b4" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Delhi High Court says payments to overseas units aren't automatically taxable in India"></iframe>
The dispute involved payments made by Ranbaxy, now merged with Sun Pharmaceutical Industries Ltd, to Teva Israel under a 2011 settlement relating to the US launch of generic atorvastatin.
